Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Pyxis Oncology, Inc. (NASDAQ: PYXS)
PYXS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
376.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
299.40%
PYXS Stock Analysis
PYXS
PE Ratio:
PYXS
PEG Ratio:
Not Available
PYXS
Forward EPS Growth (12 month):
0.00%
PYXS
PS Ratio:
7.8
PYXS
PSG Ratio:
PYXS
Forward Revenue Growth (12 month):
400.00%
PYXS Articles
No data was found